MedTrace Logo

A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies

NCT01735188 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2019-03-19

No results posted yet for this study

Summary

Primary objective:

Characterize the natural history of MoCD type A in terms of survival

Secondary objectives:

1. Evaluate blood and urine for biochemical markers
2. Evaluate head circumference, seizure activity and neurologic outcomes
3. To evaluate brain MRI
4. Compare blood and urine analysis, head circumference, seizure activity and neurologic outcomes to MRI findings

Conditions

  • Molybdenum Cofactor Deficiency
  • Isolated Sulfite Oxidase Deficiency

Sponsors & Collaborators

  • Origin Biosciences

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-11-30
Completion
2016-06-30

Countries

  • United States
  • Canada
  • Germany
  • Israel
  • Italy
  • Japan
  • Malaysia
  • Netherlands
  • Poland
  • Saudi Arabia
  • Spain
  • Tunisia
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01735188 on ClinicalTrials.gov